BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12162230)

  • 1. Decreasing blood product requirements after orthotopic liver transplantation.
    Gordon PC; James MF; Spearman CW; Millar AJ; Kahn D
    S Afr J Surg; 2002 May; 40(2):46-8. PubMed ID: 12162230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the utilization of blood components in San Pablo Hospital; 1991-1996.
    Hunter Mellado R
    Bol Asoc Med P R; 1997; 89(1-3):4-8. PubMed ID: 9168628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
    Massicotte L; Lenis S; Thibeault L; Sassine MP; Seal RF; Roy A
    Liver Transpl; 2006 Jan; 12(1):117-23. PubMed ID: 16382461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique.
    Mangus RS; Kinsella SB; Nobari MM; Fridell JA; Vianna RM; Ward ES; Nobari R; Tector AJ
    Transplant Proc; 2007 Dec; 39(10):3207-13. PubMed ID: 18089355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.
    de Boer MT; Christensen MC; Asmussen M; van der Hilst CS; Hendriks HG; Slooff MJ; Porte RJ
    Anesth Analg; 2008 Jan; 106(1):32-44, table of contents. PubMed ID: 18165548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin reduces the need for blood products during liver transplantation.
    Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
    Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation.
    Hilmi I; Horton CN; Planinsic RM; Sakai T; Nicolau-Raducu R; Damian D; Gligor S; Marcos A
    Liver Transpl; 2008 Apr; 14(4):504-8. PubMed ID: 18383079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation.
    Li M; Zhang LP; Yang L
    Chin Med J (Engl); 2007 Nov; 120(22):1963-8. PubMed ID: 18067779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications.
    Harvey MP; Greenfield TP; Sugrue ME; Rosenfeld D
    Med J Aust; 1995 Oct; 163(7):356-9. PubMed ID: 7565259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
    Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
    Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Goal-directed" transfusion management leads to distinct reduction of fluid requirement in liver transplantation.
    Gerlach H; Rossaint R; Bechstein WO; Blumhardt G; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):282-5. PubMed ID: 7689753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitability of casemix classification for output funding of blood services in Victoria. Victorian Blood Users Group.
    Whyte GS; Brook CW
    Med J Aust; 1998 Oct; 169(8):415-8. PubMed ID: 9830388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion increases the risk of postoperative infection after cardiovascular surgery.
    Banbury MK; Brizzio ME; Rajeswaran J; Lytle BW; Blackstone EH
    J Am Coll Surg; 2006 Jan; 202(1):131-8. PubMed ID: 16377506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict.
    Steib A; Freys G; Lehmann C; Meyer C; Mahoudeau G
    Can J Anaesth; 2001 Dec; 48(11):1075-9. PubMed ID: 11744582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
    Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
    Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study.
    Ak K; Isbir CS; Tetik S; Atalan N; Tekeli A; Aljodi M; Civelek A; Arsan S
    J Card Surg; 2009; 24(4):404-10. PubMed ID: 19583608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.